Signum Biosciences' Series B Round

Signum Biosciences raised a round of funding on July 25, 2011. Investors include Maple Engine.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Series B Round: